Idiopathic Pulmonary Fibrosis – get informed with this new infographic and find out why you need to know about IPF


Idiopathic Pulmonary Fibrosis IPF  infographic

Idiopathic Pulmonary Fibrosis IPF infographic


In 2013 the government invested only £600,000 in Idiopathic Pulmonary Fibrosis (IPF) research – leukaemia research received over £32m from all sources, – despite the fact IPF kills more people each year than leukaemia.

Funding for research of the disease is also significantly lower than for other conditions – in 2013 the government invested only £600,000 in IPF research – leukaemia research received over £32m from all sources.

There are estimated to be around 15,000 people living with IPF in the UK. 5,000 of those will be dead within a year, while over 5,000 more will be diagnosed within the same period. Comparatively 2,600 people are diagnosed with leukaemia each year.

The number of people with IPF in the UK is increasing by around 5% a year. It can progress very quickly with half of IPF patients dying, usually of respiratory failure, within three years of diagnosis.
Those affected by the condition are joining together to mark IPF awareness week by calling for more research and support for IPF patients and their families.

Find out more at our WebTv show here.

Idiopathic Pulmonary Fibrosis – IPF Awareness Week WebTV show


Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Join Dr Klaus Dugi and Steven Wibberley on this live, interactive and informative show where we discuss the serious disease IPF (Idiopathic Pulmonary Fibrosis).

Show date: 05 October 2015

Show time: 14:00

 With Evel Knievel among its famous sufferers, Idiopathic pulmonary fibrosis (IPF) is a very serious and ultimately fatal interstitial lung disease, killing more people in the UK than leukaemia. However, many of us have never even heard of the condition let alone the severity of it meaning it is often spotted very late.

On this special live and interactive show, broadcast during World IPF week to raise awareness, we are joined by Dr Klaus Dugi (Medical Director, Boehringer Ingleheim UK and Ireland) and Steven Wibberley, (Chief Operating Officer, British Lung Foundation) as they educate us on how to spot the signs and symptoms in yourself and in other people, the importance of early diagnosis and treatment and enlighten us on everything you may not have known about IPF.

Submit your questions prior or during the live show here